Paxman AB (publ) Share Price Nasdaq Stockholm
Equities
SE0009806284
Medical Equipment, Supplies & Distribution
Sales 2023 | 210M 19.58M 1.54B | Sales 2024 * | 292M 27.21M 2.14B | Capitalization | 844M 78.66M 6.2B |
---|---|---|---|---|---|
Net income 2023 | 8M 745K 58.73M | Net income 2024 * | 34M 3.17M 250M | EV / Sales 2023 | 3.33 x |
Net cash position 2023 * | 19M 1.77M 139M | Net cash position 2024 * | 42M 3.91M 308M | EV / Sales 2024 * | 2.75 x |
P/E ratio 2023 |
83.6
x | P/E ratio 2024 * |
24.7
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 36.29% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Paxman
CEO | Chief Executive Officer | 41 | 19/12/16 |
Director of Finance/CFO | 44 | 29/02/20 | |
Patrick Burke
CTO | Chief Tech/Sci/R&D Officer | 65 | 31/12/08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Björn Littorin
BRD | Director/Board Member | 77 | 30/11/16 |
Chairman | 70 | 30/11/16 | |
Maria Bech
BRD | Director/Board Member | 56 | 19/12/16 |
1st Jan change | Capi. | |
---|---|---|
-5.31% | 181B | |
-1.21% | 108B | |
-5.53% | 66.57B | |
+1.22% | 49.95B | |
+7.03% | 43.84B | |
+4.91% | 41.71B | |
+21.96% | 31.59B | |
+14.45% | 25.3B | |
-4.81% | 23.83B |